Aridis Pharmaceuticals Inc (ARDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,371 | -42,193 | -22,333 | -29,681 | -22,105 |
| Depreciation Amortization | 487 | 435 | 337 | 338 | 283 |
| Accounts receivable | -1,000 | N/A | N/A | 1,660 | -1,660 |
| Accounts payable and accrued liabilities | -2,932 | 2,654 | -83 | -469 | 1,297 |
| Other Working Capital | -1,299 | 10,517 | -617 | 18,223 | -2,515 |
| Other Operating Activity | 5,988 | 5,651 | 2,220 | 1,770 | 429 |
| Operating Cash Flow | $-29,127 | $-22,936 | $-20,476 | $-8,159 | $-24,271 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -82 | -530 | -367 | -174 | -1,677 |
| Investing Cash Flow | $-82 | $-530 | $-367 | $-174 | $-1,677 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,000 | 5,000 | 715 | N/A | N/A |
| Debt Repayment | -1,800 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 12,612 | 29,720 | 7,963 | 4,993 | 25,089 |
| Other Financing Activity | -1,030 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $14,782 | $34,720 | $8,678 | $4,993 | $25,089 |
| Beginning Cash Position | 19,986 | 8,732 | 20,897 | 24,237 | 25,096 |
| End Cash Position | 5,559 | 19,986 | 8,732 | 20,897 | 24,237 |
| Net Cash Flow | $-14,427 | $11,254 | $-12,165 | $-3,340 | $-859 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,127 | -22,936 | -20,476 | -8,159 | -24,271 |
| Capital Expenditure | -82 | -530 | -367 | -174 | -1,677 |
| Free Cash Flow | -29,209 | -23,466 | -20,843 | -8,333 | -25,948 |